• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Poisoning with tilidine and naloxone: toxicokinetic and clinical observations.

作者信息

Regenthal R, Krüger M, Richter M, Preiss R

机构信息

Institute of Clinical Pharmacology, University of Leipzig, Germany.

出版信息

Hum Exp Toxicol. 1998 Nov;17(11):593-7. doi: 10.1177/096032719801701101.

DOI:10.1177/096032719801701101
PMID:9865414
Abstract

The opioid analgesic tilidine and its metabolites were detected by high performance liquid chromatography (HPLC) with UV-detection in serum from a 28 year-old woman who ingested 100 ml Valoron (o)N containing 6.94 g of tilidine and about 0.56 g of naloxone with suicidal intention. Data on the toxicokinetics of tilidine in severe poisonings are missing. Therefore we followed serum concentrations of tilidine and metabolites for 48 or 96 h and for the first time calculated basic kinetic parameters in a massive life threatening poisoning. Serum concentration of tilidine 3 h after ingestion was 38.1 mg/l which is about 70 times of the upper therapeutic level in man and about ninefold above toxic concentrations known so far. The concentration of nortilidine, the primary active metabolite at this time was 18.8 mg/l. The terminal elimination half life's of tilidine and nortilidine were explicit, prolonged with 23.9 and 13.9 h respectively. The competitive opiate antagonist naloxone, which is added as a part of the industrially produced preparation Valoron N solution to minimise oral abuse is not able to prevent ventilatory depression in massive overdoses.

摘要

相似文献

1
Poisoning with tilidine and naloxone: toxicokinetic and clinical observations.
Hum Exp Toxicol. 1998 Nov;17(11):593-7. doi: 10.1177/096032719801701101.
2
Pharmacokinetics of nortilidine and naloxone after administration of tilidine/naloxone solution or tilidine/naloxone sustained release tablets.给予替利定/纳洛酮溶液或替利定/纳洛酮缓释片后去甲替利定和纳洛酮的药代动力学
Arzneimittelforschung. 2000 Nov;50(11):1015-22. doi: 10.1055/s-0031-1300326.
3
Poisoning and severe ventilatory depression after oral ingestion of the industrially produced analgesic mixture tilidine with naloxone (Valoron N solution).
Intensive Care Med. 1998 Jul;24(7):746. doi: 10.1007/s001340050657.
4
Bioavailability investigation of a new tilidine/naloxone liquid formulation compared to a reference formulation.一种新型替利定/纳洛酮液体制剂与参比制剂的生物利用度研究。
Arzneimittelforschung. 1999 Jul;49(7):599-607. doi: 10.1055/s-0031-1300469.
5
Pharmacokinetics of tilidine and naloxone in patients with severe hepatic impairment.替利定和纳洛酮在严重肝功能损害患者中的药代动力学。
Arzneimittelforschung. 2007;57(2):106-11. doi: 10.1055/s-0031-1296591.
6
Actions of tilidine and nortilidine on cloned opioid receptors.替利定和去甲替利定对克隆阿片受体的作用。
Eur J Pharmacol. 2005 Jan 4;506(3):205-8. doi: 10.1016/j.ejphar.2004.11.020. Epub 2004 Dec 15.
7
Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine.CYP2C19 和 CYP3A4 对前药替利定转化为活性去甲替利定的贡献。
Br J Clin Pharmacol. 2012 Nov;74(5):854-63. doi: 10.1111/j.1365-2125.2012.04261.x.
8
Sequential first-pass metabolism of nortilidine: the active metabolite of the synthetic opioid drug tilidine.去甲替利定的序贯首过代谢:合成阿片类药物替利定的活性代谢产物。
J Clin Pharmacol. 2002 Nov;42(11):1257-61. doi: 10.1177/009127002762491352.
9
Pre-systemic elimination of tilidine: localization and consequences for the formation of the active metabolite nortilidine.替利定的首过消除:活性代谢产物去甲替利定形成的定位及影响
Basic Clin Pharmacol Toxicol. 2015 Feb;116(2):129-33. doi: 10.1111/bcpt.12328. Epub 2014 Oct 7.
10
Comparison of tilidine/naloxone, tramadol and bromfenac in experimental pain: a double-blind randomized crossover study in healthy human volunteers.替利定/纳洛酮、曲马多和溴芬酸在实验性疼痛中的比较:一项针对健康人类志愿者的双盲随机交叉研究。
Int J Clin Pharmacol Ther. 1999 Aug;37(8):377-85.

引用本文的文献

1
In vitro metabolism of the opioid tilidine and interaction of tilidine and nortilidine with CYP3A4, CYP2C19, and CYP2D6.阿片类药物替利定的体外代谢以及替利定和去甲替利定与CYP3A4、CYP2C19和CYP2D6的相互作用。
Naunyn Schmiedebergs Arch Pharmacol. 2008 Sep;378(3):275-82. doi: 10.1007/s00210-008-0294-7. Epub 2008 May 31.
2
Pharmacological treatments for persistent non-malignant pain in older persons.老年人持续性非恶性疼痛的药物治疗
Drugs Aging. 2004;21(1):19-41. doi: 10.2165/00002512-200421010-00003.